Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yu-Han Wang

Showing results (111-120 of 114) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 114 results.
Cancer Research|March 12, 2020
Targeting Glycosylated PD-1 Induces Potent Antitumor ImmunityLinlin Sun, Chia-Wei Li, Ezra M Chung, et al.
ACS Nano|March 7, 2022
Using Exciton/Trion Dynamics to Spatially Monitor the Catalytic Activities of MoS<sub>2</sub> during the Hydrogen Evolution ReactionFu-He Hsiao, Cheng-Chu Chung, Chun-Hao Chiang, et al.
Nature Communications|May 14, 2021
Human ribonuclease 1 serves as a secretory ligand of ephrin A4 receptor and induces breast tumor initiationHeng-Huan Lee, Ying-Nai Wang, Wen-Hao Yang, et al.
The Journal of Clinical Investigation|June 3, 2025
FGFR3-induced Y158 PARP1 phosphorylation promotes PARP inhibitor resistance via BRG1/MRE11-mediated DNA repair in breast cancer modelsMei-Kuang Chen, Hirohito Yamaguchi, Yuan Gao, et al.
Pageof 12

Showing results (111-120 of 114) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 114 results.
Cancer Research|March 12, 2020
Targeting Glycosylated PD-1 Induces Potent Antitumor ImmunityLinlin Sun, Chia-Wei Li, Ezra M Chung, et al.
ACS Nano|March 7, 2022
Using Exciton/Trion Dynamics to Spatially Monitor the Catalytic Activities of MoS<sub>2</sub> during the Hydrogen Evolution ReactionFu-He Hsiao, Cheng-Chu Chung, Chun-Hao Chiang, et al.
Nature Communications|May 14, 2021
Human ribonuclease 1 serves as a secretory ligand of ephrin A4 receptor and induces breast tumor initiationHeng-Huan Lee, Ying-Nai Wang, Wen-Hao Yang, et al.
The Journal of Clinical Investigation|June 3, 2025
FGFR3-induced Y158 PARP1 phosphorylation promotes PARP inhibitor resistance via BRG1/MRE11-mediated DNA repair in breast cancer modelsMei-Kuang Chen, Hirohito Yamaguchi, Yuan Gao, et al.
Pageof 12